Literature DB >> 21429547

Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells.

Li Zhou1, Xiao-Dong He, Jian-Chun Yu, Rou-Li Zhou, Yi Shan, Jing-An Rui.   

Abstract

BACKGROUND: It was shown previously that LAPTM4B promoted growth of gallbladder carcinoma (GBC) cells and predicted poor prognosis in GBC; however, its roles and relative mechanisms in apoptosis of GBC cells remain unknown.
METHODS: The plasmids, pcDNA3-AE, containing the complete open reading frame of LAPTM4B and Mock (pcDNA3), were transfected transiently into GBC-SD cells, followed by induction of apoptosis by epirubicin. Cell apoptosis was determined by Hoechst 33258 staining, propidium iodide (PI) staining, and Annexin V/PI double staining flow cytometry. Protein expression was detected by immunoblotting.
RESULTS: Overexpression of LAPTM4B-35 was observed in cells transfected with pcDNA3-AE. These cells possessed significantly less apoptosis ratios compared with cells transfected with the Mock plasmid, although the values were still greater than those in parent cells. Of the apoptosis-related molecules, expression of Bcl-2 and Bcl-xL was up-regulated in cells transfected with pcDNA3-AE, whereas expressions of Bax, Bid, and cleaved caspase-9 and -3 were down-regulated compared with their expression in other kinds of cells.
CONCLUSION: Our data show that LAPTM4B-35 attenuated epirubicin-induced apoptosis of GBC-SD cells in vitro through a mitochondria-dependent pathway. Therefore, the protein LAPTM4B-35 might be associated with the chemoresistance of GBC.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21429547     DOI: 10.1016/j.surg.2010.12.010

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  16 in total

1.  Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.

Authors:  Min Xiao; Shusheng Jia; Hongbin Wang; Jinsong Wang; Yuanxi Huang; Zhigao Li
Journal:  J Cancer Res Clin Oncol       Date:  2013-01-06       Impact factor: 4.553

2.  Overexpression of LAPTM4B is correlated with tumor angiogenesis and poor prognosis in non-small cell lung cancer.

Authors:  Han Tang; Hui Tian; Weiming Yue; Lin Li; Shuhai Li; Cun Gao; Libo Si; Lei Qi; Ming Lu
Journal:  Med Oncol       Date:  2014-05-11       Impact factor: 3.064

3.  Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.

Authors:  Man Qiao; Guohua Hu
Journal:  Tumour Biol       Date:  2015-04-25

4.  Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.

Authors:  Fanling Meng; Shu Tan; Tianbo Liu; Hongtao Song; Ge Lou
Journal:  Tumour Biol       Date:  2015-11-02

5.  LAPTM4B allele *2 is a marker of poor prognosis following hepatic tumor resection for hepatocellular carcinoma.

Authors:  Hua Yang; Guojun Zhai; Xiaoxu Ji; Fuxia Xiong; Jing Su; Michael A McNutt
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

6.  LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.

Authors:  Xiaojing Cheng; Zhixue Zheng; Zhaode Bu; Xiaojiang Wu; Lianhai Zhang; Xiaofang Xing; Xiaohong Wang; Ying Hu; Hong Du; Lin Li; Shen Li; Rouli Zhou; Xian-Zi Wen; Jia-Fu Ji
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

7.  Reversing multidrug resistance in Caco-2 by silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL using liposomal antisense oligonucleotides.

Authors:  Yu-Li Lo; Yu Liu
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

8.  Analysis of single nucleotide polymorphism in adolescent idiopathic scoliosis in Korea: for personalized treatment.

Authors:  Eun Su Moon; Hak Sun Kim; Veushj Sharma; Jin Oh Park; Hwan Mo Lee; Sung Hwan Moon; Hyon Su Chong
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

9.  cAMP responsive element binding protein-1 is a transcription factor of lysosomal-associated protein transmembrane-4 Beta in human breast cancer cells.

Authors:  Meng Zhang; Jian-Jun Xu; Rou-Li Zhou; Qing-Yun Zhang
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

Review 10.  LAPTM4B: an oncogene in various solid tumors and its functions.

Authors:  Y Meng; L Wang; D Chen; Y Chang; M Zhang; J-J Xu; R Zhou; Q-Y Zhang
Journal:  Oncogene       Date:  2016-05-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.